多组学分析揭示特应性皮炎与银屑病中的宿主-微生物相互作用
本研究纳入成人慢性特应性皮炎(AD)、斑块型银屑病(PSO)患者及健康志愿者,采集皮损与非皮损皮肤微生物组和活检组织,用全宏基因组鸟枪法测序分析微生物群落,SparCC构建真菌-细菌共现网络,O2PLS整合宿主转录组与微生物特征。结果显示两病均存在马拉色菌属重构及皮损处真菌-细菌生态连接性降低,AD中马拉色菌丰度随疾病严重度增加而降低并与炎症免疫细胞特征负相关,PSO中马拉色菌组成改变与IL-17驱动转录程序及脂质代谢通路相关。
要点
- AD和PSO皮损均存在马拉色菌属重构及真菌-细菌生态连接性降低。
- AD中马拉色菌与金黄色葡萄球菌负相关,并连接抗菌肽及IL-17信号模块。
- AD中马拉色菌丰度随疾病严重度增加而降低,与炎症免疫细胞特征负相关。
核心结论
- AD和PSO中真菌-细菌相互作用破坏与免疫激活相关,AD中真菌失衡还与疾病严重度相关。
- 皮肤微生物组特征可能为疾病监测、患者分层及未来微生物组导向治疗提供临床相关信息。
研究设计与样本
- 纳入成人慢性AD、斑块型PSO患者及健康志愿者,采集皮损与非皮损皮肤微生物组样本和活检组织。
- AD取样部位为大腿后侧,PSO为下背部。
- 采用全宏基因组鸟枪法测序分析微生物群落,SparCC构建真菌-细菌共现网络,O2PLS整合宿主转录组与微生物特征。
主要发现
- AD和PSO皮损均显示疾病相关的马拉色菌属重构及真菌-细菌生态连接性降低。
- AD中马拉色菌与金黄色葡萄球菌负相关,并连接以抗菌肽为中心、富集IL-17信号的宿主基因模块。
- AD中马拉色菌丰度随疾病严重度增加而降低,并与炎症免疫细胞特征负相关。
- PSO中马拉色菌组成改变与IL-17驱动转录程序及脂质代谢通路相关。
临床怎么用
- 皮肤真菌-细菌互作特征有望用于AD和PSO的疾病监测与患者分层。
- 未来可探索免疫靶向治疗联合恢复微生物平衡的个体化管理策略。
局限性
- 研究结论仍需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) and psoriasis (PSO) are chronic inflammatory skin diseases that impose substantial physical and psychological burdens. Although fungal-bacterial balance is important for skin immune homeostasis, the role of the skin mycobiome and its interaction with bacterial communities and host immunity in these diseases remains poorly understood. OBJECTIVES: To characterize alterations in the skin mycobiome and its interactions with bacterial communities and host immune responses in AD and PSO. METHODS: Adult patients with chronic AD, plaque-type PSO and healthy volunteers were included in this study. Skin microbiota samples and biopsies were collected from lesional and non-lesional skin areas, including the posterior thigh for AD and the lower back for PSO. Whole-metagenome shotgun sequencing was used to profile microbial communities. SparCC was used to construct fungal-bacterial co-occurrence networks, and integration of host transcriptomic and microbial features was performed using O2PLS. RESULTS: Both AD and PSO showed disease-associated restructuring of Malassezia species and reduced fungal-bacterial ecological connectivity in lesional skin. In AD, Malassezia arunalokei was inversely associated with Staphylococcus aureus and linked to antimicrobial peptide-centred host gene modules enriched for IL-17 signalling. Its abundance decreased with increasing disease severity and inversely correlated with inflammatory immune cell signatures. In PSO, altered Malassezia composition was associated with IL-17-driven transcriptional programmes and lipid metabolic pathways, suggesting interactions between fungal imbalance and inflammatory-metabolic processes. CONCLUSIONS: Our findings expand current models of skin dysbiosis beyond bacteria and suggest that disrupted fungal-bacterial interactions are linked to immune activation in AD and PSO and, in AD, to disease severity. Although further validation is required, skin microbiome features may provide clinically relevant information for disease monitoring, patient stratification and future microbiome-informed therapeutic strategies. Our study lays the groundwork for microbiome modulation as a potential therapeutic strategy for AD and PSO. Atopic dermatitis (AD) and psoriasis (PSO) are common long‐term inflammatory skin diseases that can cause itching, redness and various comorbidities, often affecting quality of life. While most previous research has focused on skin bacteria, less is known about the role of fungi and how they interact with bacteria and the human immune system. In this study, we analysed skin samples from patients with AD and PSO, as well as healthy individuals, using sequencing‐based approaches to examine both bacterial and fungal communities, together with gene expression analyses to assess immune activity in the skin. We found that in both diseases, the normal balance between fungi and bacteria is disrupted. In AD, certain fungal species that are more common in healthy skin were reduced, whereas bacteria such as Staphylococcus aureus increased and were linked to stronger immune responses and more severe disease. In PSO, changes in fungal composition were associated with inflammation and alterations in skin metabolism. These findings suggest that changes in the skin microbiome are closely linked to disease activity. Microbial patterns may help to monitor disease progression or identify patients at higher risk of worsening symptoms. In the future, treatments that combine immune‐targeted therapies with approaches to restore microbial balance may offer more personalized ways to manage these conditions.
引用
- Yang Y, Olah P, Salava A, et al. Multi-omics analyses reveal host-microbe interactions in atopic dermatitis and psoriasis. J Eur Acad Dermatol Venereol. 2026. PMID: 42554585. doi:10.1111/jdv.70654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。